About Oregon Pharma Services
Oregon Pharma Services was a Healthcare company based in Mumbai (India) by Vikas Alurkar and Guillermo Gutierrez Israel. It manufactures high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Manufacturing and Drug Production. Its legal entity in India is Oregon Pharma Services Private Limited (U74120MH2013PTC240389). Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Oregon Pharma Services operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug production. Manufactures high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Mumbai, India
- Founders Vikas Alurkar, Guillermo Gutierrez Israel
- SectorsHealthcare
- Website oregonindia.com
- Legal Name Oregon Pharma Services Private Limited
- Date of Incorporation 12 Feb, 2013
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹71,762
FY 2021
- Net Loss-₹12.3 Lakh
FY 2021 · -1708% margin
- EBITDA-₹12 Lakh
FY 2021 · -1666% margin
Associated legal entities of Oregon Pharma Services
Oregon Pharma Services operates through Oregon Pharma Services Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Oregon Pharma Services Private Limited CIN U74120MH2013PTC240389 | Strike Off | 12 Feb 2013 | Mumbai, Maharashtra | ₹0.0 Cr | – | 2 | View details |
Board of directors of Oregon Pharma Services Private Limited (Oregon Pharma Services)
Oregon Pharma Services Private Limited is the primary company behind Oregon Pharma Services. The board of Oregon Pharma Services Private Limited currently have 2 directors; the longest-serving is Vikas Rajaram Alurkar, appointed in 2013. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikas Rajaram Alurkar DIN 06508445 | Director | 23 Feb 2013 | 13 yrs 7 mo | Oregon Pharma Services Private Limited |
| Shrikant Kisan Thombre DIN 06527956 | Director | 29 Mar 2021 | 5 yrs 6 mo | Oregon Pharma Services Private Limited |
People of Oregon Pharma Services
2 people are tracked at Oregon Pharma Services (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Oregon Pharma Services
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Oregon Pharma Services
Figures of Oregon Pharma Services Private Limited, the primary company behind Oregon Pharma Services, for FY 2021. Revenue was ₹71,762. Net loss was -₹12.3 Lakh (-1708% margin). EBITDA was -₹12 Lakh (-1666% margin). Revenue has grown at a compounded annual rate of -80% over three years and -61% over five years.
- ₹71,762Revenue · FY 2021
- -₹12.3 LakhNet loss · -1708% margin
- -₹12 LakhEBITDA · -1666% margin
- ₹1 LakhPaid-up capital
- -80%Revenue CAGR, 3 years
- -61%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Oregon Pharma Services Private Limited are on its company page.
Detailed financial statements for Oregon Pharma Services
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Oregon Pharma Services
Oregon Pharma Services has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Oregon Pharma Services
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Oregon Pharma Services (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oregon Pharma Services
Oregon Pharma Services is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Oregon Pharma Services, Oregon Pharma Services Private Limited, reported revenue of ₹71,762 for FY 2021.
Oregon Pharma Services operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug production. Manufactures high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Oregon Pharma Services's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Oregon Pharma Services operates through Oregon Pharma Services Private Limited.
The legal entities of Oregon Pharma Services currently have 2 directors, including Vikas Rajaram Alurkar, Shrikant Kisan Thombre.